Delivery Order SPE2DB24D9238-SPE2DB25FDQYC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on July 21, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and will be performed at the awardee's Park Ridge location. The order is funded through the Defense Logistics Agency's Medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $198,126 by the Defense Logistics Agency on August 19, 2025. The delivery order is for EYLEA HD 8 mg/0.07 ml vial medication, with an ultimate completion date of September 10, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status. The place...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,943.78 by the Defense Logistics Agency on July 31, 2025. The contract calls for delivery of EYLEA HD 8 mg/0.07 ml vials, a pharmaceutical product used to treat eye conditions, with an ultimate completion date of August 21, 2025. The award was issued without a set-aside designation and specifies Park Ridge, Illinois as...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29.3 thousand by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract covers the delivery of EYLEA 2 mg/0.05 ml syringes to support federal healthcare requirements, with an ultimate completion date of August 18, 2025. This delivery order was issued without a set-aside designation and is...
- The U.S. Defense Logistics Agency has awarded a firm fixed-price delivery order contract worth $12,919.30 to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the delivery of EYLEA 2 MG/0.05 ML syringes, and has a completion date of February 28, 2024. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, that DMS Pharmaceutical Group holds with the Defense Logistics Agency. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,925.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, with a period of performance through April 8, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,081.24 by the Defense Logistics Agency on August 11, 2025, for the supply of EYLEA 2 mg/0.05 ml vials. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 2, 2025. No set-aside designation was applied to this award. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The U.S. Department of Defense's Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,761.76 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a medication, with a period of performance through September 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $24,446.00 for EYLEA 2 mg/0.05 mL syringes. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on July 30, 2025, is scheduled for ultimate completion by August 20, 2025, with performance taking place in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQYCDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,906.30 by the Defense Logistics Agency on August 4, 2025. The delivery order, contract number 4568997402, is for EYLEA HD 8 mg/0.07 ml vials, with an ultimate completion date of August 25, 2025. This award was made without a set-aside designation, allowing the contractor to compete directly in the federal marketplace. The place of performance is Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. Under the SPE2DB program, this IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. EYLEA HD is a biopharmaceutical product used in ophthalmologic treatment, and this delivery order represents one of numerous pharmaceutical distributions the contractor provides to Department of Defense healthcare sites across the federal supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 8/4/25 |